These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2792909)
1. Flow-cytometric prognostic factors for the survival of patients with ovarian carcinoma: a 5-year follow-up study. Volm M; Kleine W; Pfleiderer A Gynecol Oncol; 1989 Oct; 35(1):84-9. PubMed ID: 2792909 [TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors. Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DNA content in epithelial ovarian cancer. Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021 [TBL] [Abstract][Full Text] [Related]
4. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Volm M; Hahn EW; Mattern J; Müller T; Vogt-Moykopf I; Weber E Cancer Res; 1988 May; 48(10):2923-8. PubMed ID: 2834052 [TBL] [Abstract][Full Text] [Related]
5. Prediction of long-term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer. Friedlander ML; Hedley DW; Swanson C; Russell P J Clin Oncol; 1988 Feb; 6(2):282-90. PubMed ID: 3276825 [TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma. Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994 [TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
8. Influence of cellular DNA content on survival in ovarian carcinoma. Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056 [TBL] [Abstract][Full Text] [Related]
9. Clinical value of morphometric and DNA flow cytometric variables as independent predictors of survival in epithelial ovarian carcinoma: a 5-year follow-up study. Veerman MM; van der Wurff AA; van de Water M; Kruitwagen RF; Feijen HW; Vos MC Int J Gynecol Pathol; 2009 Sep; 28(5):432-41. PubMed ID: 19696612 [TBL] [Abstract][Full Text] [Related]
10. [Demonstration of independent cellular prognostic factors in squamous cell carcinoma of the lung]. Volm M; Kayser K; Mattern J Strahlenther Onkol; 1989 Aug; 165(8):587-92. PubMed ID: 2772815 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of flow cytometric DNA content analysis in granulosa cell tumor of the ovary. Klemi PJ; Joensuu H; Salmi T Cancer; 1990 Mar; 65(5):1189-93. PubMed ID: 2302667 [TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary. Brescia RJ; Barakat RA; Beller U; Frederickson G; Suhrland MJ; Dubin N; Demopoulos RI Cancer; 1990 Jan; 65(1):141-7. PubMed ID: 2293860 [TBL] [Abstract][Full Text] [Related]
13. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. A five-year follow up study. Volm M; Mattern J; Müller T; Drings P Anticancer Res; 1988; 8(1):105-12. PubMed ID: 3358625 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle flow cytometric analysis in the diagnosis and management of colorectal carcinoma. Sampedro A; Salas-Bustamante A; López-Artimez M; García-Muñíz JL; Urdiales G Anal Quant Cytol Histol; 1999 Aug; 21(4):347-52. PubMed ID: 10560513 [TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of flow cytophotometric studies in ovarian cancer]. Volm M; Kleine W Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study. Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479 [TBL] [Abstract][Full Text] [Related]
17. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas. Rutgers DH; Wils IS; Schaap AH; van Lindert AC Pathol Res Pract; 1987 Apr; 182(2):207-13. PubMed ID: 3601797 [TBL] [Abstract][Full Text] [Related]
18. Influence of cellular DNA content on survival in advanced ovarian cancer. Friedlander ML; Hedley DW; Taylor IW; Russell P; Coates AS; Tattersall MH Cancer Res; 1984 Jan; 44(1):397-400. PubMed ID: 6690054 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas. Volm M; Drings P; Kleine W; Mattern J Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331 [TBL] [Abstract][Full Text] [Related]
20. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate. Meyer JS; Gersell DJ; Yim S Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]